CLINICAL ROLE -
Navigating Drug Resistance in Chronic Myelocytic Leukemia
Opportunities for further optimization of CML management remain.
Oral Oncolytics Expand Armamentarium in HR+/HER– Early-Stage Breast Cancer in Adjuvant Setting
New agents can offer a more tailored approach to therapy selection.
Brown Bag Consult®: Melanoma
Melanoma is responsible for 80% of skin cancer deaths.
Updates in Prostate Cancer Treatment
New therapeutics for prostate cancer must continue to be assessed for comparative safety and efficacy, as well as accessibility for patients.
2 Clarke Drive Cranbury, NJ 08512